Rivanna Medical is a Charlottesville, VA company focused on elevating standards of care through imaging-based medical solutions. Its flagship effort, Accuro XV, integrates ultrasound-based bone and 3D soft-tissue imaging with AI-enabled software to rapidly detect skeletal fractures and soft-tissue injuries without radiation exposure or extensive operator training. The platform builds on the firm’s proprietary technologies, including BoneVision Multi-Probe Multi-Angle Image Acquisition, BoneEnhance Multi-Frequency Image Reconstruction, and SpineNav3D AI-Enabled Spine Recognition. Current development priorities include completing advanced product work and submitting Accuro XV for FDA 510(k) clearance, followed by AI-enabled CADe/x fracture detection capabilities. Clinical objectives aim to expedite triage of low-acuity extremity injuries, particularly in mass-casualty scenarios, while reducing unnecessary radiography. Rivanna received an $11.6 million base BARDA contract in 2021 and has now secured a larger follow-on award to advance the product toward commercialization.

Total raised

$33M

Funding rounds

4

Latest round

Grant

Latest activity

Aug 2025